Back to Search
Start Over
Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice
- Source :
- Diabetes. April 2004, Vol. 53 Issue 4, p931, 8 p.
- Publication Year :
- 2004
-
Abstract
- The metabolic syndrome (visceral obesity, insulin resistance, type 2 diabetes, and dyslipidemia) resembles Cushing's Syndrome, but without elevated circulating glucocorticoid levels. An emerging concept suggests that the aberrantly elevated levels of the intracellular glucocorticoid reamplifying enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) found in adipose tissue of obese humans and rodents underlies the phenotypic similarities between idiopathic and 'Cushing-oid' obesity. Transgenic overexpression of 11β-HSD-1 in adipose tissue reproduces a metabolic syndrome in mice, whereas 11β-HSD-1 deficiency or inhibition has beneficial metabolic effects, at least on liver metabolism. Here we report novel protective effects of 11β-HSD-1 deficiency on adipose function, distribution, and gene expression in five in 11β-HSD-1 nullizygous (11β-HSD-[1.sup.-/-]) mice. 11β-HSD-[1.sup.-/-] mice expressed lower resistin and tumor necrosis factor-α, but higher peroxisome proliferator-activated receptor-γ, adiponectin, and uncoupling protein-2 mRNA levels in adipose, indicating insulin sensitization. Isolated 11β-HSD-[1.sup.-/-] adipocytes exhibited higher basal and insulin-stimulated glucose uptake, 11β-HSD-[1.sup.-/-] mice also exhibited reduced visceral fat accumulation upon high-fat feeding. High-fat-fed 11β-HSD-[1.sup.-/-] mice rederived onto the C57BL/6J strain resisted diabetes and weight gain despite consuming more calories. These data provide the first in vivo evidence that adipose 11β-HSD-1 deficiency beneficially alters adipose tissue distribution and function, complementing the reported effects of hepatic 11β-HSD-1 deficiency or inhibition.<br />Chronic exposure to high circulating glucocorticoid levels (Cushing's syndrome) causes visceral obesity and the associated metabolic abnormalities of insulin resistance, type 2 diabetes, dyslipidemia, and hypertension. Similar metabolic abnormalities occur [...]
- Subjects :
- Obesity -- Causes of -- Case studies -- Risk factors -- Research -- Care and treatment
Diabetes -- Care and treatment -- Research -- Case studies -- Risk factors
Insulin resistance -- Risk factors -- Research -- Case studies -- Care and treatment
Health
Care and treatment
Research
Case studies
Risk factors
Causes of
Subjects
Details
- Language :
- English
- ISSN :
- 00121797
- Volume :
- 53
- Issue :
- 4
- Database :
- Gale General OneFile
- Journal :
- Diabetes
- Publication Type :
- Periodical
- Accession number :
- edsgcl.115408037